Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were slightly lower Friday morning, driven by several companies issuing disappointing guidance or announcing negative news. Ross Stores (ROST) shares fell over 11% after projecting Q2 EPS of $1.40-$1.55, below the $1.65 analyst estimate despite beating Q1 earnings and revenue expectations; Deckers Outdoor (DECK) also declined sharply after issuing weaker-than-expected Q1 revenue and EPS guidance. Other notable pre-market decliners included Bicara Therapeutics (BCAX), Gyre Therapeutics (GYRE), Hallador Energy (HNRG), Xerox (XRX), MINISO Group (MNSO), SBC Medical Group (SBC), Workday (WDAY), and Navitas Semiconductor (NVTS).

Analysis

U.S. stock futures indicated a slightly weaker open, with Dow futures declining approximately 0.1% on Friday, reflecting a market sentiment heavily influenced by a series of adverse corporate updates. Ross Stores (ROST) saw its shares fall 11.2% in pre-market trading to $135.00 despite exceeding first-quarter earnings expectations with $1.47 per share (versus $1.44 estimated) and revenue of $4.99 billion (versus $4.97 billion consensus); the decline was primarily attributed to its second-quarter GAAP EPS guidance of $1.40-$1.55, which fell below the $1.65 analyst consensus, suggesting potential concerns over future profitability or growth deceleration. Similarly, Deckers Outdoor Corporation (DECK) shares dropped 16% after providing first-quarter revenue guidance of $890 million to $910 million, short of the $925.86 million estimate, and EPS guidance of 62 to 67 cents, trailing the 81 cents consensus, following its fourth-quarter fiscal 2025 results. Other significant pre-market decliners included Bicara Therapeutics (BCAX), down 20.2% due to mixed Phase 1/1b trial results for ficerafusp alfa; Xerox Holdings Corporation (XRX), which lost 9.6% after reducing its quarterly dividend substantially from $0.125 to $0.025 per share, signaling potential financial constraints or a strategic capital reallocation; Gyre Therapeutics (GYRE), falling 14.4% upon announcing the pricing of a $20.0 million public stock offering; and Workday (WDAY), declining 6.5% after issuing second-quarter sales guidance below analyst estimates. Navitas Semiconductor (NVTS) also experienced a 6.3% dip, possibly reflecting profit-taking after a remarkable 164% surge the previous day spurred by its collaboration with Nvidia. The collective impact of these individual company challenges contributes to an overall strongly negative market sentiment, underscored by a -0.7 sentiment score, centered on corporate earnings outlooks and fundamental company-specific issues.

Key Decisions for Investors

• Given the broad pre-market weakness driven by disappointing corporate guidance and negative company-specific news, investors should exercise heightened scrutiny over their holdings and remain alert to potential near-term market volatility.
• Re-evaluate positions in companies like Ross Stores and Deckers Outdoor that have issued forward-looking guidance significantly below analyst expectations, as this could indicate emerging operational challenges or sector-specific headwinds.
• Particular caution is warranted for stocks facing substantial negative catalysts, such as Xerox's significant dividend cut, Bicara Therapeutics' inconclusive clinical trial data, or Gyre Therapeutics' dilutive equity offering, which may necessitate a thorough reassessment of their respective investment theses.
• For stocks like Navitas Semiconductor, which experienced a sharp pullback following a substantial recent gain, investors should monitor whether this represents short-term profit-taking or a more fundamental shift in sentiment, particularly in relation to its recent positive news.